retatrutide and periods VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide UK 2026: Phase 3

Others may need a slower titration, a dose adjustment, or a discussion about long-term medication strategy

Keep in mind that weight loss happens gradually, even when you are taking GLP-1 medications

To be eligible for the plan, members must: Be enrolled in a standalone prescription drug plan (PDP), like Part D, or a Medicare Advantage (MA) plan Use GLP-1 medications to treat excess body weight and maintain weight loss Meet all clinical criteria Clinical criteria for Medicare GLP-1 Bridge program To qualify clinically, a health care provider must submit a prior authorization stating the medication is prescribed to reduce excess body weight and maintain weight reduction. The medication must also be used alongside current and ongoing lifestyle modifications, including a nutrition plan and consistent physical activity

When you eat less food, you consume fewer electrolytes

Diabetes monitoring : For patients with type 2 diabetes, closely monitor blood glucose levels when resuming semaglutide, as your insulin sensitivity and glucose control may have changed during the perioperative period, especially if dietary patterns or activity levels have been altered